← All trials
NCT03751007
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 27, 2018
- Primary completion
- Dec 31, 2019
- Completion date
- Jun 30, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 48
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- IntrexonLead sponsor
- TFS Trial Form SupportCollaborator
- Yale UniversityOverall official - principal investigator
- Katholieke Universiteit LeuvenOverall official - principal investigator
- Precigen ActobioCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.